Một lưỡi dao hai lưỡi: tổng quan về sự tương tác giữa sức khỏe thể chất và sức khỏe tinh thần

Langan J, Mercer SW, Smith DJ (2013) Multimorbidity and mental health: can psychiatry rise to the challenge? Br J Psychiatry 202:391–393 Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet 380(9836):37–43 Emanuel EJ (2012) Where are the health care cost savings? JAMA 307(1):39–40 Naylor C, Parsonage M, McDaid D et al. (2012) Long-term conditions and mental health: The cost of co-morbidities. The King’s Fund Williams S, Dale J (2006) The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 94(3):372–390 Chapman DP, Perry GS, Strine TW (2005) The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2(1):A14 McNamee L, Mead G, MacGillivray S et al (2013) Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry 203:239–241 A vision for change (2006) Report of the expert group on mental health policy. Dublin http://www.dohc.ie/publications/pdf/vision_for_change.pdf. Accessed 21 Feb 2013 Schizophrenia: Core interventions in the treatment and management of adults with schizophrenia in primary and secondary care. NICE Clinical Guideline 178 (2014) London: NICE http://www.nice.org.uk/nicemedia/live/11786/43608/43608.pdf. Accessed 21 Feb 2013 De Hert M, Cohen D, Bobes J et al (2011) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10(2):138–151 Cradock-O’Leary J, Young AS, Yano EM et al (2002) Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 53(7):874–878 Lawrence D, Kisely S (2010) Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol 24(4 Suppl):61–68 Royal College of Psychiatrists (2012) Report of the national audit of schizophrenia (NAS) 2012. Healthcare Quality Improvement Partnership, London Kessler RC, Berglund P, Demler O et al (2003) National comorbidity survey replication. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289(23):3095–3105 Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55(7):580–592 Benton T, Staab J, Evans DL (2007) Medical co-morbidity in depressive disorders. Ann Clin Psychiatry 19(4):289–303 Pan A, Lucas M, Sun Q et al (2010) Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 170(21):1884–1891 Patten SB, Williams JV, Lavorato DH et al (2009) Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med 71(3):273–279 Sullivan MD, Katon WJ, Lovato LC et al (2013) Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 10:1041–1047 MacHale S (2002) Managing depression in physical illness. Adv Psychiatr Treat 8(4):297–305 Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952 Healthy active lives (HeAL): keeping the body in mind in youth with psychosis (2013) http://www.iphys.org.au/HeAL_declaration.pdf The Schizophrenia Commission (2012) The abandoned illness: a report from the Schizophrenia Commission. Rethink Mental Illness, London Andreassen OA, Djurovic S, Thompson WK et al (2013) Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 92(2):197–209 Lahti M, Tiihonen J, Wildgust H et al (2012) Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychol Med 42:1–11 Dee A, Perry IJ, Staines A et al (2012) Executive summary: the cost of overweight and obesity on the island of Ireland. http://www.safefood.eu/SafeFood/media/SafeFoodLibrary/Documents/Publications/Research%20Reports/Final-Exec-Summary-The-Economic-Cost-of-Obesity.pdf. Accessed 01/02/2013 Behan C, McGlade N, Haq F et al (2008) Physical health and attendance at primary care in people with schizophrenia. Ir J Psychol Med 25(2):57–60 de Vegt F, Dekker JM, Jager A et al (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285(16):2109–2113 Jagun O, Chan G, Tee WJ et al (2013) Guesstimating body mass index (BMI): how good are we really? Gut 62:A38. doi:10.1136/gutjnl-2013-305143.91 Husin M, Kasim S, Tuthill A (2012) Accuracy of visual estimation in diagnosing obese individuals-a blinded study. Br J Med Pract 5(2) Vancampfort D, Knapen J, De Hert M et al (2009) Cardiometabolic effects of physical activity interventions for people with schizophrenia. Physical Ther Rev 14(6):388–398 McCreadie RG (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 183:534–539 Craft LL, Perna FM (2004) The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry 6(3):104–111 Barry MM, van Lente E, Molcho M et al (2009) SLÁN 2007: Survey of lifestyle, attitudes and nutrition in Ireland: Mental health and social well-being report. Department of Health and Children. The Stationery Office, Dublin Myles N, Newall HD, Curtis J et al (2012) Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry 73(4):468–475 De Hert M, Dekker JM, Wood D et al (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24(6):412–424 Zhang XY, Chen DC, Xiu MH et al (2012) Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. Psychol Med 1–10 McNeill A (2001) Smoking and mental health: a review of the literature. In Symposium report: Smoking and mental health. Smoke-free London Campion J, Checinski K, Nurse J (2008) Review of smoking cessation treatments for people with mental illness. Adv Psychiatr Treat 14(3):208–216 Winterbourne S (2012) Preventing future physical morbidity and premature mortality in first-episode psychosis patients: an economic evaluation of smoking cessation interventions. Dissertation London School of Economics and Social Policy Holt RIG, Peveler RC (2010) Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future. Pract Diabetes Internatl 27(2):79–84 Ryan MC, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160(2):284–289 Fiedorowicz JG, Miller DD, Bishop JR et al (2012) Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers. Curr Psychiatry Rev 8(1):25–36 Gorczynski P, Faulkner G (2010) Exercise therapy for schizophrenia. Schizophr Bull 36(4):665–666 Smith SM, Soubhi H, Fortin M et al (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345:e5205 Hasnain M, Fredrickson SK, Vieweg WVR et al (2010) Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Curr Diab Rep 10(3):209–216 Corrigan PW, Larson JE, Ruesch N (2009) Self-stigma and the “why try” effect: impact on life goals and evidence-based practices. World Psychiatry 8(2):75–81 Thornicroft G (2011) Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 199:441–442